Verdict Medical Devices

Tempus partners with Verastem for companion diagnostic development

Tempus AI is expanding its partnership with Verastem Oncology to develop a companion diagnostic (CDx) for the latter’s KRAS-mutant recurrent LGSOC combination treatment. The post Tempus partners with Verastem for companion diagnostic development appeared first on Medical Device Network.

May 20, 2025 - 16:50
 0
Tempus partners with Verastem for companion diagnostic development
Tempus AI is expanding its partnership with Verastem Oncology to develop a companion diagnostic (CDx) for the latter’s KRAS-mutant recurrent LGSOC combination treatment.

The post Tempus partners with Verastem for companion diagnostic development appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Haute Wine Society And Simon Family Estate Celebrate Chef Josiah Citrin

Next Article

FDA clears Trax Surgical’s compression staple system for orthopaedic use

Related Posts

Are regulators keeping pace with AI adoption in clinical trials?

Are regulators keeping pace with AI adoption in clinica...

May 16, 2025  0

Republicans’ proposed Medicaid cuts met with dismay

Republicans’ proposed Medicaid cuts met with dismay

May 13, 2025  0

Innovative Health awarded $147m in antitrust lawsuit against J&J’s Biosense Webster

Innovative Health awarded $147m in antitrust lawsuit ag...

May 20, 2025  0